Frontline immune checkpoint inhibitor-based combination therapy in metastatic renal cell carcinoma patients with poor performance status.

Autor:	Carril-Ajuria, Lucía1 (AUTHOR), Colomba, Emeline1 (AUTHOR), Romero-Ferreiro, Carmen2,3 (AUTHOR), Cerbone, Luigi1 (AUTHOR), Ratta, Raffaele4 (AUTHOR), Barthelemy, Philippe5 (AUTHOR), Vindry, Clarisse6 (AUTHOR), Fléchon, Aude6 (AUTHOR), Cherifi, François7 (AUTHOR), Boughalem, Elouen8 (AUTHOR), Linassier, Claude9 (AUTHOR), Fornarini, Giuseppe10 (AUTHOR), Rebuzzi, Sara E.10 (AUTHOR), Gross-Goupil, Marine11 (AUTHOR), Saldana, Carolina12 (AUTHOR), Martin-Soberón, Maricruz13 (AUTHOR), de Velasco, Guillermo13 (AUTHOR), Manneh, Ray14 (AUTHOR), Pernaut, Cristina15 (AUTHOR), Sanchez de Torre, Ana16 (AUTHOR)
Zdroj:	European Journal of Cancer. Feb2023, Vol. 180, p21-29. 9p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect